Home CannaBusiness

CannaBusiness

Leafbuyer Technologies, Inc. Continues Growth by Signing Contracts with Two Major Dispensary Chains

DENVER–(BUSINESS WIRE)–Leafbuyer Technologies, Inc. (LBUY) (“Leafbuyer”), a leading cannabis technology platform, announced today that it has entered into expansion agreements with two major dispensary chains, Sweet Leaf Marijuana Centers and Green Dragon Cannabis Co. The Sweet Leaf Dispensary Chain owns and operates 10 locations across Colorado and one in Portland, Oregon. The Green Dragon Can December 7, 2017

CanniMed Therapeutics Inc. Announces Medical Cannabis Supply Agreement with PharmaChoice

SASKATOON, Saskatchewan–(BUSINESS WIRE)–CanniMed Therapeutics Inc. (TSX: CMED) (“CanniMed”) is pleased to announce that it has entered into a definitive agreement with PharmaChoice for supply of CanniMed’s herbal, oils and oil derivative cannabis products to PharmaChoice’s over 750 pharmacy locations across Canada. Pursuant to the agreement, PharmaChoice has committed exclusively to CanniMed as its sole sup December 6, 2017

TSX Defers Consideration of CanniMed Therapeutics Shareholder Rights Plan

SASKATOON, Saskatchewan–(BUSINESS WIRE)–CanniMed Therapeutics Inc. (“CanniMed” or the “Company”) (TSX: CMED) today announced that it has been notified by the Toronto Stock Exchange (the “TSX“) that the TSX will, in accordance with the practice of the TSX in connection with similar rights plans, defer consideration of the acceptance of the Company’s previously announced Shareholder R December 5, 2017

The Leafly Guide to Cannabis: A Handbook for the Modern Consumer

From the world’s leading cannabis experts at Leafly.com Available now SEATTLE–(BUSINESS WIRE)–Leafly, the world’s most popular cannabis website, is now available on your bookshelf. The first-ever book from Leafly’s award-winning expert team, The Leafly® Guide to Cannabis: A Handbook for the Modern Consumer (Twelve Books, December 2017, Hardcover & eBook) is a definitive gui December 5, 2017

Tilray Continues to Execute EU Expansion Strategy by Exporting Medical Cannabis to the Czech Republic

PRAGUE–(BUSINESS WIRE)–Tilray, a global pioneer in medical cannabis research, production, and distribution, today announced that is has successfully exported dried medical cannabis products to the Czech Republic for nationwide distribution to qualified patients through hospitals, pharmacies, and clinics. Tilray’s entry into the Czech market is another strategic milestone for the company as it continu December 5, 2017

CannaKids CEO Tracy Ryan Defends Use of Pediatric Medical Cannabis Against FDA Officials on "The Doctors"

Viewers Can Tune in on December 5, December 4, 2017 /CBS LOS ANGELES–(BUSINESS WIRE)–On Tuesday December 5th, CannaKids CEO Tracy Ryan will make her daytime talk debut on the CBS Emmy award-winning program, “The Doctors.” Tracy and Dr. Bonni Goldstein (MD, of Canna-Centers Wellness and Education), will debate former-FDA Division Director Daniel Fabricant, Ph.D., on […]

22nd Century Hires Former BAT Head of Plant Biotechnology

Juan Sanchez Tamburrino, Ph.D., will take over for retiring Michael R. Moynihan, Ph.D. CLARENCE, N.Y.–(BUSINESS WIRE)–22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company focused on tobacco harm re December 4, 2017 /cannabis research, announced today the hiring of Juan Sanchez Tamburrino, Ph.D., as the Company’s Vice President of Research and Development. Dr. Tamburrino was […]

Actions Versus Words: Aurora CEO’s Actions Reveal That Aurora Stock is Inflated; Insiders Sell $17 Million in Stock During Their Hostile Take-over Bid for CanniMed and During a Financing

Despite trying to convince CanniMed shareholders to take Aurora’s shares in their opportunistic and coercive hostile bid, Aurora insiders’ cash out evidences their belief that Aurora’s shares are inflated Shareholders are advised to take NO ACTION regarding the unsolicited bid SASKATOON, Saskatchewan–(BUSINESS WIRE)–CanniMed Therapeutics Inc. (“CanniMed” or the “Company”) (TSX: CMED) draws the attenti November 30, 2017

22nd Century Ships 2.4 Million SPECTRUM® Cigarettes for the National Institute on Drug Abuse

XXII’s Proprietary Very Low Nicotine research cigarettes demonstrate the feasibility of FDA’s plan to dramatically reduce nicotine in cigarettes CLARENCE, N.Y.–(BUSINESS WIRE)–22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company focused on tobacco harm re November 30, 2017 /cannabis research, announced today that the Company shipped 2.4 million SPECTRUM® research cigarettes for the National Institute […]